Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12616000636459
Ethics application status
Approved
Date submitted
12/05/2016
Date registered
17/05/2016
Date last updated
16/06/2017
Type of registration
Prospectively registered
Titles & IDs
Public title
Early Capsule Endoscopy in Acute Upper Gastrointestinal Bleeding.
Query!
Scientific title
A prospective randomised control trial of Early Capsule Endoscopy in patients with Acute Upper Gastrointestinal Bleeding.
Query!
Secondary ID [1]
289208
0
Nil known
Query!
Universal Trial Number (UTN)
U1111-1182-8556
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Acute upper gastrointestinal bleeding
298764
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
298814
298814
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
This research involves procedures and clinical care which are performed as standard practice currently. Patients with a negative gastroscopy will be randomised to either the control group and receive a Colonoscopy, or the intervention group and receive a Capsule Endoscopy as their second investigation.
Those patients randomised to the Capsule Endoscopy group will be orally administered a single disposable endoscopy capsule which will pass through the gastrointestinal tract taking continuous images that will be sent to a data receiver, This data will be downloaed and interpreted by a trained gastroenterologist. This will all be completed during athe same inpatient hospital admission.
Query!
Intervention code [1]
294742
0
Diagnosis / Prognosis
Query!
Comparator / control treatment
Patients in the control group will be randomised to receive a colonoscopy following a negative gastroscopy, which is part of current standard clinical practice. A consultant gastroenterologist will perform the procedure of approximately 30 minutes duration, with anaesthesia provided by a consultant anaesthetist.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
298286
0
The primary outcome will be the proportion of patients in whom a source of bleeding is identified on capsule endoscopy or colonoscopy.
Query!
Assessment method [1]
298286
0
Query!
Timepoint [1]
298286
0
The primary timepoint will be 1 day after the colonoscopy or capsule endoscopy.
Query!
Secondary outcome [1]
323750
0
A secondary outcome will be number of blood transfusions received by a patient which will be determined through review of their electronic medical records.
Query!
Assessment method [1]
323750
0
Query!
Timepoint [1]
323750
0
3 months after initial presentation
Query!
Secondary outcome [2]
323751
0
A secondary outcome will be length of hospital stay which will be determined through review of electronic medical records.
Query!
Assessment method [2]
323751
0
Query!
Timepoint [2]
323751
0
3 months after initial presentation
Query!
Secondary outcome [3]
323752
0
A secndary outcome will be number of hospital representations which will be determined through review of the electronic medical records.
Query!
Assessment method [3]
323752
0
Query!
Timepoint [3]
323752
0
3 months after initial presentation
Query!
Eligibility
Key inclusion criteria
Participants will be males or females who present with acute melaena and/or haematemesis and have a negative gastroscopy.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Patients less than 18 years of age and pregnant females will be excluded form this study.
Query!
Study design
Purpose of the study
Diagnosis
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation not concealed
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
15/06/2016
Query!
Actual
1/05/2017
Query!
Date of last participant enrolment
Anticipated
1/12/2017
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
60
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment hospital [1]
5794
0
Gold Coast Hospital - Southport
Query!
Recruitment postcode(s) [1]
13237
0
4215 - Southport
Query!
Funding & Sponsors
Funding source category [1]
293583
0
Hospital
Query!
Name [1]
293583
0
Gold Coast University Hospital
Query!
Address [1]
293583
0
Gold Coast University Hospital
1 Hospital Blvd
Southport, 4215, QLD
Query!
Country [1]
293583
0
Australia
Query!
Primary sponsor type
Government body
Query!
Name
QLD Health
Query!
Address
Gold Coast University Hospital
1 Hospital Blvd
Southport, 4215, QLD
Query!
Country
Australia
Query!
Secondary sponsor category [1]
292405
0
None
Query!
Name [1]
292405
0
Query!
Address [1]
292405
0
Query!
Country [1]
292405
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
295031
0
Gold Coast Hospital and Health Services Human Research Ethics Committee
Query!
Ethics committee address [1]
295031
0
Gold Coast University Hospital 1 Hospital Blvd, Southport, QLD, 4215
Query!
Ethics committee country [1]
295031
0
Australia
Query!
Date submitted for ethics approval [1]
295031
0
11/05/2016
Query!
Approval date [1]
295031
0
07/07/2016
Query!
Ethics approval number [1]
295031
0
Query!
Summary
Brief summary
All patients with upper gastrointestinal bleeding (UGIB) undergo a gastroscopy urgently. However, in a significant proportion of these patients a source is not identified. Small bowel bleeding is highly likely to be the source in a large number of these patients. This may be identified by capsule endoscopy. Proximal colonic bleeding is also likely in patients with melaena and is identifiable by colonoscopy. As per current standard practice, patients will undergo a colonoscopy frequently or a capsule endoscopy (CE) less often, in an attempt to find the cause of bleeding. Capsule endoscopy is noninvasive, better tolerated and preferred by patients as bowel prep and anaesthesia are not required. However,it is uncertain who will benefit most by having a capsule endoscopy as the second test. The focus of our study is to look at the subgroup of patients who will benefit most by having early Capsule Endoscopy in this context. The study aims to compare two groups of patients, one having capsule endoscopy VS the other having colonoscopy as the second test following a negative gastroscopy to determine differences in ability to detect bleeding source and therefore change patient outcome. All patients with UGIB with a negative gastroscopy will be considered for the study. This is a prospective randomised control trial. Primary endpoint measured will be identification of the source of bleeding. Secondary endpoints measured will be reduced blood transfusions, reduced length of stay, reduced number of investigations and reduced hospital admissions.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Attachments [1]
880
880
0
0
/AnzctrAttachments/370693-Research Protocol - Early Capsule Endoscopy.docx
Query!
Query!
Contacts
Principal investigator
Name
65830
0
Dr Tegan Stevenson
Query!
Address
65830
0
Gold Coast University Hospital,
1 Hospital Blvd
Southport, QLD, 4215
Query!
Country
65830
0
Australia
Query!
Phone
65830
0
+61405736406
Query!
Fax
65830
0
Query!
Email
65830
0
[email protected]
Query!
Contact person for public queries
Name
65831
0
Tegan Stevenson
Query!
Address
65831
0
Gold Coast University Hospital,
1 Hospital Blvd
Southport, QLD, 4215
Query!
Country
65831
0
Australia
Query!
Phone
65831
0
+61405736406
Query!
Fax
65831
0
Query!
Email
65831
0
[email protected]
Query!
Contact person for scientific queries
Name
65832
0
Tegan Stevenson
Query!
Address
65832
0
Gold Coast University Hospital,
1 Hospital Blvd
Southport, QLD, 4215
Query!
Country
65832
0
Australia
Query!
Phone
65832
0
+61405736406
Query!
Fax
65832
0
Query!
Email
65832
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF